市場調查報告書
商品編碼
1492605
馬醫療保健市場:按產品、應用和最終用戶 - 2024-2030 年全球預測Equine Healthcare Market by Product (Diagnostics tools, Feed Supplements, Pharmaceuticals), Application (Diagnosis, Monitoring & Therapy, Surgical Application), End-User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年馬匹保健市場規模為32.5億美元,預計2024年將達34.6億美元,2030年將達50.7億美元,複合年成長率為6.52%。
馬匹醫療保健包括一系列旨在維持和改善馬匹健康和福利的服務、治療和產品。獸醫學專業包括馬匹特有的疾病、傷害和病症的預防保健、診斷、治療和管理。馬保健的重要內容包括常規疫苗接種、牙科護理、營養護理、寄生蟲控制和緊急醫療服務。馬醫療保健還包括使用先進的診斷工具、外科手術、物理治療和馬匹復健。馬的保健重點是預防措施和治療性介入,對於確保馬的壽命、性能和生活品質至關重要。馬匹保健市場的成長是由於馬術運動的日益普及、出於休閒和陪伴目的的馬主數量的增加以及對動物健康和福利意識的提高而推動的。然而,嚴格的藥品核准監管要求正在挑戰馬保健市場的擴張。為了維持馬匹醫療保健市場的成長並滿足未來的需求,將基於遺傳見解的個人化遠端醫療與用於遠距離診斷和治療的遠距醫療相結合對於研發部門至關重要。
主要市場統計 | |
---|---|
基準年[2023] | 32.5億美元 |
預測年份 [2024] | 34.6億美元 |
預測年份 [2030] | 50.7億美元 |
複合年成長率(%) | 6.52% |
區域洞察
在美洲,美國擁有大量馬匹,賽馬文化蓬勃發展,並在以疾病預防、治療和福利為重點的醫療保健服務方面投入大量資金。美國正在展示馬匹健康的創新,包括基因療法和旨在早期發現和預防疾病的數位健康監測系統的最新專利。加拿大對馬匹的護理和治療實施了嚴格的監管標準,以確保馬匹獲得最高水準的醫療保健。這些法規涵蓋了廣泛的業務,從疾病預防和控制到動物的人道待遇。都市化的加速、可支配收入的增加以及對馬術運動的興趣日益濃厚,為亞太地區馬術保健市場的擴張做出了重大貢獻。中國的重點是在政府支持和私人投資的支持下改善育種方法和疾病控制。日本完善的賽馬業對先進的醫療保健和治療的需求不斷成長。印度的馬匹醫療保健產業受益於旨在提高品種品質和改善獸醫護理基礎設施的舉措,從而促進了整體市場的成長。 EMEA(歐洲、中東和非洲)地區多元化,歐盟國家傳統上是馬術運動和馬匹醫療保健的大本營。歐洲、中東和非洲地區的馬匹保健市場受到多種因素的推動,包括賽馬、體育和休閒活動的日益普及,這些活動涉及需要定期健康檢查和保養的馬匹。先進的育種技術和預防性馬匹保健在中東越來越受歡迎。中東在馬匹福利、育種和醫療保健方面投入巨資,阿拉伯聯合大公國等先進設施代表了所提供的高標準護理。基因研究和血統保存非常重要,並且正在分配大量資金來保護阿拉伯馬的遺產和表現。在非洲地區,特別是南非,賽馬界的發展和對馬術運動的熱情推動了馬匹醫療保健的採用。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在馬醫療保健市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢驗了與商務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對馬保健市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對目前在馬醫療保健市場中的地位進行全面評估,使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[186 Pages Report] The Equine Healthcare Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.46 billion in 2024, at a CAGR 6.52% to reach USD 5.07 billion by 2030.
Equine healthcare encompasses a broad range of services, practices, and products aimed at maintaining and enhancing the health and well-being of horses. This specialized field of veterinary medicine includes preventive care, diagnosis, treatment, and management of illnesses, injuries, and disorders specific to horses. The critical components of equine healthcare involve routine vaccinations, dental care, nutritional management, parasite control, and emergency medical services. Equine healthcare includes using advanced diagnostic tools, surgical procedures, physiotherapy, and rehabilitation for equines. With a focus on preventive measures and therapeutic interventions, equine healthcare is crucial in ensuring horses' longevity, performance, and quality of life. The growth of the equine healthcare market is driven by the rising popularity of equine sports, increased horse ownership for leisure and companionship, and a growing awareness of animal health and welfare. However, stringent regulatory requirements for drug approval act as a challenge to expanding the equine healthcare market. Personalized medicine based on genetic insights and the incorporation of telemedicine for remote diagnostics and treatment is vital for research and development areas to sustain equine healthcare market growth and address future demands.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 3.25 billion |
Estimated Year [2024] | USD 3.46 billion |
Forecast Year [2030] | USD 5.07 billion |
CAGR (%) | 6.52% |
Regional Insights
In the Americas, the U.S. has a substantial equine population and a prevalent horse racing culture, investing heavily in healthcare services, focusing on disease prevention, treatment, and welfare. The U.S. showcases innovations in equine health, demonstrated by the latest patents in gene therapy and digital health monitoring systems designed for early disease detection and prevention. Canada has implemented stringent regulatory standards that govern the care and treatment of equines, ensuring they receive the highest level of healthcare. These regulations cover a wide range of practices, from disease prevention and control to the humane treatment of animals. The increasing urbanization, disposable income, and a growing interest in equestrian sports have significantly contributed to expanding the equine healthcare market in the Asia Pacific region. In China, the focus remains on improving breeding methods and disease management, backed by governmental support and private investments. Japan's well-established racing industry propels the need for advanced healthcare and therapeutics. The equine healthcare sector in India is benefitting from initiatives aimed at improving breed quality and veterinary care infrastructure, contributing to the market's overall growth. The EMEA region presents a diverse picture, with EU countries traditionally strongholds in equestrian sports and, thus, equine healthcare. In the EMEA region, the equine healthcare market is driven by several factors, including the increasing popularity of horse racing, sports, and leisure activities involving horses, which necessitate regular health check-ups and maintenance. Advanced reproductive technologies and preventive equine healthcare are gaining traction in the Middle East. The Middle East invests heavily in equine welfare, breeding, and healthcare, and the advanced facilities in countries such as the United Arab Emirates epitomize the high standard of care provided. Genetic research and preservation of bloodlines are significant, with substantial funding allocated to safeguarding the heritage and performance of Arabian equines. In the African region, particularly in South Africa, the adoption of equine healthcare is propelled by the growing horse racing community and enthusiasm for equine sports.
Market Insights
The market dynamics represent an ever-changing landscape of the Equine Healthcare Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Equine Healthcare Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Equine Healthcare Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Neogen Announced Biosecurity Partnership with TerraNova
Neogen Corporation announced a partnership with TerraNova. The partnership is poised to leverage TerraNova's innovative biosecurity solutions alongside Neogen's extensive repertoire of animal safety products, aiming to significantly elevate hygiene and disease prevention standards in equine environments. Neogen and TerraNova are dedicated to delivering unparalleled expertise and solutions through the partnership, addressing the pressing need for holistic and effective biosecurity practices in the realm of equine healthcare. [Published On: 2023-12-05]
Hilltop Bio Launched Strydaflex for Equine Joints
Hilltop Bio announced the launch of StrydaFlex, an advanced therapy explicitly designed for equine healthcare. The novel product addresses a wide range of significant health concerns that are prevalent among horses, including joint issues and inflammation, by harnessing advanced biotechnology methods. [Published On: 2023-04-25]
Covetrus Launches SmartImmune Mushroom to Help Support Powerful Immune Defense in Horses
Covetrus introduced SmartImmune Mushroom, an innovative product designed to bolster the immune defenses of horses. The latest addition to Covetrus's portfolio is the culmination of extensive research into equine health needs. SmartImmune Mushroom leverages the natural immune-supporting properties of mushrooms, offering a powerful yet holistic approach to enhance equine well-being. [Published On: 2023-04-05]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Equine Healthcare Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Equine Healthcare Market, highlighting leading vendors and their innovative profiles. These include Alltech Inc., Archer-Daniels-Midland Company, Bayer AG, Belvoir Equine Limited, Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Sante Animale, Covetrus, Inc., Dechra Pharmaceuticals PLC, ELANCO ANIMAL HEALTH INCORPORATED, ESAOTE SPA, Hallmarq Veterinary Imaging Inc., Hilltop Biosciences, IDEXX Laboratories, Inc., Kent Nutrition Group, Land O'Lakes, Inc., Merck & Co., Inc., Mg Biologics, Neogen Corporation, Platinum Performance, Inc., Sanofi S.A., Vetoquinol S.A., W.F. Young, Inc., and Zoetis Inc..
Market Segmentation & Coverage